These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 20602988

  • 1. Oxalate-degrading bacteria of the human gut as probiotics in the management of kidney stone disease.
    Abratt VR, Reid SJ.
    Adv Appl Microbiol; 2010; 72():63-87. PubMed ID: 20602988
    [Abstract] [Full Text] [Related]

  • 2. Association of intestinal oxalate-degrading bacteria with recurrent calcium kidney stone formation and hyperoxaluria: a case-control study.
    Tavasoli S, Alebouyeh M, Naji M, Shakiba Majd G, Shabani Nashtaei M, Broumandnia N, Basiri A.
    BJU Int; 2020 Jan; 125(1):133-143. PubMed ID: 31145528
    [Abstract] [Full Text] [Related]

  • 3. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy.
    Sidhu H, Schmidt ME, Cornelius JG, Thamilselvan S, Khan SR, Hesse A, Peck AB.
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S334-40. PubMed ID: 10541258
    [Abstract] [Full Text] [Related]

  • 4. Metabolic activity of probiotics-oxalate degradation.
    Murphy C, Murphy S, O'Brien F, O'Donoghue M, Boileau T, Sunvold G, Reinhart G, Kiely B, Shanahan F, O'Mahony L.
    Vet Microbiol; 2009 Apr 14; 136(1-2):100-7. PubMed ID: 19028028
    [Abstract] [Full Text] [Related]

  • 5. A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease.
    Siva S, Barrack ER, Reddy GP, Thamilselvan V, Thamilselvan S, Menon M, Bhandari M.
    BJU Int; 2009 Jan 14; 103(1):18-21. PubMed ID: 19021605
    [Abstract] [Full Text] [Related]

  • 6. Oxalate consumption by lactobacilli: evaluation of oxalyl-CoA decarboxylase and formyl-CoA transferase activity in Lactobacillus acidophilus.
    Turroni S, Vitali B, Bendazzoli C, Candela M, Gotti R, Federici F, Pirovano F, Brigidi P.
    J Appl Microbiol; 2007 Nov 14; 103(5):1600-9. PubMed ID: 17953571
    [Abstract] [Full Text] [Related]

  • 7. Screening of different probiotic strains for their in vitro ability to metabolise oxalates: any prospective use in humans?
    Mogna L, Pane M, Nicola S, Raiteri E.
    J Clin Gastroenterol; 2014 Nov 14; 48 Suppl 1():S91-5. PubMed ID: 25291139
    [Abstract] [Full Text] [Related]

  • 8. Stable expression of the oxc and frc genes from Oxalobacter formigenes in human embryo kidney 293 cells: implications for gene therapy of hyperoxaluria.
    Ye ZQ, Kong DB, Chen ZQ, Yao LF, Guo H, Yu X, Liu GL, Yang WM.
    Int J Mol Med; 2007 Oct 14; 20(4):521-6. PubMed ID: 17786282
    [Abstract] [Full Text] [Related]

  • 9. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration.
    Campieri C, Campieri M, Bertuzzi V, Swennen E, Matteuzzi D, Stefoni S, Pirovano F, Centi C, Ulisse S, Famularo G, De Simone C.
    Kidney Int; 2001 Sep 14; 60(3):1097-105. PubMed ID: 11532105
    [Abstract] [Full Text] [Related]

  • 10. Oxalate degrading bacteria: new treatment option for patients with primary and secondary hyperoxaluria?
    Hoppe B, von Unruh G, Laube N, Hesse A, Sidhu H.
    Urol Res; 2005 Nov 14; 33(5):372-5. PubMed ID: 16284877
    [Abstract] [Full Text] [Related]

  • 11. Oxalate-degrading microorganisms or oxalate-degrading enzymes: which is the future therapy for enzymatic dissolution of calcium-oxalate uroliths in recurrent stone disease?
    Peck AB, Canales BK, Nguyen CQ.
    Urolithiasis; 2016 Feb 14; 44(1):45-50. PubMed ID: 26645869
    [Abstract] [Full Text] [Related]

  • 12. Role of gut microbiota against calcium oxalate.
    Sadaf H, Raza SI, Hassan SW.
    Microb Pathog; 2017 Aug 14; 109():287-291. PubMed ID: 28624518
    [Abstract] [Full Text] [Related]

  • 13. Diversity of faecal oxalate-degrading bacteria in black and white South African study groups: insights into understanding the rarity of urolithiasis in the black group.
    Magwira CA, Kullin B, Lewandowski S, Rodgers A, Reid SJ, Abratt VR.
    J Appl Microbiol; 2012 Aug 14; 113(2):418-28. PubMed ID: 22616725
    [Abstract] [Full Text] [Related]

  • 14. [Effect of oral lactosucrose supplementation on human enteric oxalate-degrading bacteria].
    Takei K, Akakura K, Ueda T, Mikami K, Ito H.
    Hinyokika Kiyo; 2006 Sep 14; 52(9):687-91. PubMed ID: 17040052
    [Abstract] [Full Text] [Related]

  • 15. Effect of a Probiotic Supplement Containing Lactobacillus Acidophilus and Bifidobacterium Animalis Lactis on Urine Oxalate in Calcium Stone Formers with Hyperoxaluria: A Randomized, Placebo-controlled, Double-blind and In-vitro Trial.
    Tavasoli S, Jalali S, Naji M, Borumandnia N, Shakiba Majd G, Basiri A, Khosravi Darani K, Karamad D, Tajabadi-Ebrahimi M, Taheri M.
    Urol J; 2021 Jun 15; 19(3):179-188. PubMed ID: 34129232
    [Abstract] [Full Text] [Related]

  • 16. Oxalate-degrading Providencia rettgeri isolated from human stools.
    Hokama S, Toma C, Iwanaga M, Morozumi M, Sugaya K, Ogawa Y.
    Int J Urol; 2005 Jun 15; 12(6):533-8. PubMed ID: 15985073
    [Abstract] [Full Text] [Related]

  • 17. Designer probiotic Lactobacillus plantarum expressing oxalate decarboxylase developed using group II intron degrades intestinal oxalate in hyperoxaluric rats.
    Paul E, Albert A, Ponnusamy S, Mishra SR, Vignesh AG, Sivakumar SM, Sivasamy G, Sadasivam SG.
    Microbiol Res; 2018 Oct 15; 215():65-75. PubMed ID: 30172310
    [Abstract] [Full Text] [Related]

  • 18. Development of an Innovative Method by Optimizing qPCR Technique for Isolating and Determining Oxalobacter Formigenes Microbial Load in the Stool of Patients with Urolithiasis.
    Jafari GA, Fotouhi Ardakani R, Akhavan Sepahi M, Nowroozi J, Soltanpour MS.
    Iran J Kidney Dis; 2021 May 15; 15(3):190-198. PubMed ID: 33994378
    [Abstract] [Full Text] [Related]

  • 19. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate.
    Troxel SA, Sidhu H, Kaul P, Low RK.
    J Endourol; 2003 Apr 15; 17(3):173-6. PubMed ID: 12803990
    [Abstract] [Full Text] [Related]

  • 20. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis.
    Hoppe B, von Unruh GE, Blank G, Rietschel E, Sidhu H, Laube N, Hesse A.
    Am J Kidney Dis; 2005 Sep 15; 46(3):440-5. PubMed ID: 16129205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.